J. Kjeldsen et al., SEROMARKERS OF COLLAGEN-I AND COLLAGEN-III METABOLISM IN ACTIVE CROHNS-DISEASE - RELATION TO DISEASE-ACTIVITY AND RESPONSE TO THERAPY, Gut, 37(6), 1995, pp. 805-810
Crohn's disease is characterised by gradual development of intestinal
fibrotic lesions containing large amounts of collagen type I, III, and
V. Measurement of circulating connective tissue metabolites has emerg
ed as a useful tool for assessment of fibroproliferative activity in v
arious diseases. Serum concentrations of procollagen peptides, N-termi
nal propeptide of type III procollagen (PII-INP), and C-terminal prope
ptide of type I procollagen (PICP), reflect the synthesis rate of the
parent collagens, while the C-terminal telopeptide of type I collagen
(ICTP) reflects its degradation. S-PIIINP, S-PICP, and S-ICTP were mea
sured by radioimmunoassays in 29 patients with active Crohn's disease.
S-ICTP was significantly increased, median 6.2 mu g/l (95% CI 5.2 to
8.7 mu g/l) versus controls 2.6 mu g/l (2.5 to 2.7 mu g/l) (p < 0.0001
), S-PICP reduced, 100 mu g/l (80 to 110 mu g/l) versus 132 mu g/l (12
4 to 141 mu g/l) (p=0.001), and S-PIIINP did not differ from controls.
Patients with sustained clinical remission during prednisolone therap
y exhibited an increase in S-PICP (p=0.0052). S-PIIINP changed signifi
cantly (p=0.0002), however, exhibiting a biphasic pattern. S-ICTP decr
eased (p=0.015) in treatment responders but remained above the upper n
ormal limit even when clinical remission had been achieved. Nonrespond
ers showed no significant changes in any of the marker molecules of co
llagen synthesis or degradation. Correlations were found between S-ICT
P and S-PICP (p<0.005) and S-ICTP (p<0.02), and between S-ICTP and S-o
rosomucoid (p<0.005) and S-C reactive protein (p<0.02). By contrast, t
here was no relation between the connective tissue metabolites and Har
vey Bradshaw Index. These data provide evidence that collagen I degrad
ation is increased not only in active Crohn's disease, but also in pat
ients entering clinical remission. The concurrent normal/low-normal va
lues of markers of collagen formation may reflect a changed local or s
ystemic elimination of the propeptides.